LPL Financial
MDGL icon

LPL Financial’s Madrigal Pharmaceuticals MDGL Stock Holding History

LPL Financial’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.52M Sell
8,427
-979
-10% -$501K ﹤0.01% 2899
2026
Q1 		$4.92M Sell
9,406
-7,136
-43% -$3.41M ﹤0.01% 2636
2025
Q4 		$9.63M Sell
16,542
-5,996
-27% -$3.06M ﹤0.01% 1962
2025
Q3 		$10.3M Buy
22,538
+8,417
+60% +$3.14M ﹤0.01% 1834
2025
Q2 		$4.27M Sell
14,121
-16,701
-54% -$4.98M ﹤0.01% 2446
2025
Q1 		$10.2M Buy
30,822
+25,602
+490% +$8.41M ﹤0.01% 1588
2024
Q4 		$1.61M Buy
5,220
+480
+10% +$135K ﹤0.01% 3064
2024
Q3 		$1.01M Sell
4,740
-438
-8% -$112K ﹤0.01% 3397
2024
Q2 		$1.45M Buy
5,178
+1,749
+51% +$416K ﹤0.01% 2905
2024
Q1 		$916K Sell
3,429
-143
-4% -$33.7K ﹤0.01% 3265
2023
Q4 		$826K Buy
+3,572
New +$625K ﹤0.01% 3216
2023
Q3 		– Sell
-1,010
Closed -$233K – 4753
2023
Q2 		$233K Buy
1,010
+184
+22% +$49.8K ﹤0.01% 4042
2023
Q1 		$200K Sell
826
-57
-6% -$15.5K ﹤0.01% 4048
2022
Q4 		$256K Buy
+883
New +$86.4K ﹤0.01% 3791
2022
Q2 		– Sell
-3,768
Closed -$370K – 4499
2022
Q1 		$370K Buy
+3,768
New +$318K ﹤0.01% 3412
2021
Q4 		– Sell
-2,813
Closed -$224K – 4411
2021
Q3 		$224K Sell
2,813
-205
-7% -$17.7K ﹤0.01% 3881
2021
Q2 		$294K Buy
3,018
+675
+29% +$79.9K ﹤0.01% 3603
2021
Q1 		$274K Buy
+2,343
New +$273K ﹤0.01% 3543
2019
Q1 		– Sell
-2,260
Closed -$255K – 3225
2018
Q4 		$255K Buy
2,260
+947
+72% +$147K ﹤0.01% 2593
2018
Q3 		$281K Sell
1,313
-10
-0.8% -$2.51K ﹤0.01% 2755
2018
Q2 		$370K Buy
+1,323
New +$232K ﹤0.01% 2459

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LPL Financial's MDGL Position: Q2 2026 in Review

LPL Financial reduced its Madrigal Pharmaceuticals (MDGL) stake by 10% in Q2 2026, selling an estimated $501K and leaving 8,427 shares worth $4.52M. The position accounts for ﹤0.01% of the portfolio, ranked #2899.

LPL Financial first reported a position in MDGL in Q2 2018 and has held it in 21 quarters since. The position peaked at $10.3M in Q3 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • LPL Financial held 8,427 shares of Madrigal Pharmaceuticals worth $4.52M as of Q2 2026.
  • LPL Financial sold 979 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $501K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #2899 holding.
  • LPL Financial first reported a position in Madrigal Pharmaceuticals in Q2 2018 and has held it in 21 quarters since.
  • LPL Financial's Madrigal Pharmaceuticals position peaked at $10.3M in Q3 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.